Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-09-038158

Director sold 5,000 shares at an average $3.51 ($17,525)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GREGG VALETA A · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2009-07-27 Exercise or conversion : show line 1 in the form +5,000 $0.34 $1,700 5,000 D
2009-07-27 Sale : show line 2 in the form −3,500 $3.50 $12,250 1,500 D
2009-07-27 Sale : show line 3 in the form −1,000 $3.52 $3,520 500 D
2009-07-27 Sale : show line 4 in the form −500 $3.51 $1,755 0 D
Open-market sales · 5,000 sh · avg $3.51 · $17,525

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2009-07-27 Exercise or conversion : show line 5 in the form Option to Purchase Common Shares −5,000 $0.34 $1,700 $0.34 2011-03-27 5,000 0 D
Loading xslF345X03/doc4.xml…